Published in J Pharmacol Exp Ther on October 01, 1975
Distribution of anticancer antibiotic daunomycin in the rat heart and kidney revealed by immunocytochemistry using monoclonal antibodies. Histochem Cell Biol (2006) 0.86
Improved immunocytochemical detection of daunomycin. Histochem Cell Biol (2007) 0.84
Immunocytochemical studies on the distribution pattern of daunomycin in rat gastrointestinal tract. Histochem Cell Biol (2007) 0.79
Tandem laser-induced fluorescence and mass spectrometry detection for high-performance liquid chromatography analysis of the in vitro metabolism of doxorubicin. Anal Chem (2010) 0.79
A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res (1978) 2.24
Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer (1974) 2.10
NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc Natl Acad Sci U S A (1979) 1.75
Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer (2001) 1.67
Bis-benzimidazole anticancer agents: targeting human tumour helicases. Anticancer Drug Des (1999) 1.66
Cytofluorescence localization of adriamycin and daunorubicin. Cancer Res (1974) 1.62
Biological and biochemical properties of Phaseolus vulgaris isolectins. J Biol Chem (1977) 1.55
Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase. J Biol Chem (1984) 1.54
Purification of the phytohemagglutinin family of proteins from red kidney beans (Phaseolus vulgaris) by affinity chromatography. Biochim Biophys Acta (1975) 1.52
Analyses of the factors influencing bone graft infection after delayed cranioplasty. Acta Neurochir (Wien) (2006) 1.41
Subcutaneous administration of recombinant human erythropoietin before cardiac surgery: a double-blind, multicenter trial in Japan. Transfusion (1994) 1.39
Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function. Cancer Res (1977) 1.36
Tissue distribution and disposition of daunomycin (NCS-82151) in mice: fluorometric and isotopic methods. Cancer Chemother Rep (1970) 1.26
Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation. Mol Pharmacol (1977) 1.22
Pharmacokinetics and metabolism of adriamycin in man. Clin Pharmacol Ther (1973) 1.19
Hepatic stimulator substance: physicochemical characteristics and specificity. Am J Physiol (1982) 1.18
Cytoplasmic aldo-keto reductases: a class of drug metabolizing enzymes. Science (1976) 1.16
The pharmacokinetics of daunomycin in man. Clin Pharmacol Ther (1971) 1.16
Adriamycin metabolism in man. Evidence from urinary metabolites. Drug Metab Dispos (1976) 1.14
New method for quantitative assessment of airway calibre using a stereovision fibreoptic bronchoscope. Br J Anaesth (2011) 1.01
Rat liver daunorubicin reductase. An aldo-keto reductase. J Biol Chem (1974) 0.99
Adriamycin and daunorubicin disposition in the rabbit. J Pharmacol Exp Ther (1974) 0.99
Daunomycin metabolism in rat tissue slices. J Pharmacol Exp Ther (1970) 0.99
Interleukin-1beta stimulates galectin-9 expression in human astrocytes. Neuroreport (2001) 0.98
Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography. Drug Metab Dispos (1980) 0.96
Acute doxorubicin toxicity. Relationship to pretreatment liver function, response, and pharmacokinetics in patients with acute nonlymphocytic leukemia. Cancer (1984) 0.95
Nuclear catalyzed antibiotic free radical formation. Cancer Res (1982) 0.95
Microsomal synthesis of fatty acid amides. J Biol Chem (1966) 0.95
Rat liver aldehyde reductase. Biochem Pharmacol (1977) 0.95
Cis-Dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasms. Cancer (1980) 0.94
Interferon-gamma stimulates fractalkine expression in human bronchial epithelial cells and regulates mononuclear cell adherence. Am J Respir Cell Mol Biol (2001) 0.92
Evaluation of immunochromatography tests for detection of novel GII.17 norovirus in stool samples. Euro Surveill (2015) 0.91
Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia. Cancer Res (1972) 0.91
Daunorubicinol, a major metabolite of daunorubicin: isolation from human urine and enzymatic reactions. J Pharmacol Exp Ther (1971) 0.90
Recombinations of subunits of Phaseolus vulgaris isolectins. J Biol Chem (1977) 0.89
[A surgical case report of ossified left atrial myxoma]. Nihon Kyobu Geka Gakkai Zasshi (1996) 0.89
A soluble dihydrofolate reductase from human placenta: purification and properties. Arch Biochem Biophys (1971) 0.89
Daunorubicin metabolism in acute nonlymphocytic leukemia. Clin Pharmacol Ther (1973) 0.88
Induction of a human carbonyl reductase gene located on chromosome 21. Biochim Biophys Acta (1990) 0.87
Diurnal variation of circulating human myeloid progenitor cells. Exp Hematol (1980) 0.87
[A case of Bacillus cereus prosthetic valve endocarditis]. Kyobu Geka (1994) 0.87
High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity. Cancer Treat Rep (1981) 0.86
Comparative mammalian metabolism of adriamycin and daunorubicin. Cancer Res (1978) 0.85
Familial scimitar syndrome: three-dimensional visualization of anomalous pulmonary vein in young sisters. Circulation (2001) 0.85
Biochemical activation of AZQ [3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone] to its free radical species. Cancer Treat Rep (1982) 0.84
Daunorubicin metabolism by rat tissue preparations. J Pharmacol Exp Ther (1971) 0.84
Reversal by adenosine of ADP inhibition of platelet (Na+ + K+)-ATPase. Biochim Biophys Acta (1970) 0.84
Heterogeneity of anthracycline antibiotic carbonyl reductases in mammalian livers. Biochem Pharmacol (1978) 0.84
Cytofluorescence localization of anthracycline antibiotics. Cancer Res (1980) 0.84
Adriamycin and daunorubicin inhibition of mutant T4 DNA polymerases. Proc Natl Acad Sci U S A (1974) 0.83
Alterations in adriamycin efficacy by phenobarbital. Cancer Res (1976) 0.83
Bilary disposition of adriamycin. Clin Pharmacol Ther (1977) 0.83
Mammalian carbonyl reductases. Drug Metab Rev (1980) 0.83
Doxorubicin and cisplatin excretion into human milk. Cancer Treat Rep (1985) 0.83
DNA alkylation by enzyme-activated mitomycin C. Mol Pharmacol (1986) 0.82
Preliminary studies for fluorometric determination of pyridoxal and of its 5'-phosphate. J Vitaminol (Kyoto) (1970) 0.82
Xanthine oxidase catalyzed reductive cleavage of anthracycline antibiotics and free radical formation. Mol Pharmacol (1980) 0.82
Kinetics of anthracycline antibiotic free radical formation and reductive glycosidase activity. Arch Biochem Biophys (1983) 0.82
Antihelicase action of CI-958, a new drug for prostate cancer. Cancer Chemother Pharmacol (1998) 0.82
Adriamycin: a new effective agent in the therapy of disseminated sarcomas. Med Pediatr Oncol (1975) 0.81
Comparative flavoprotein catalysis of anthracycline antibiotic. Reductive cleavage and oxygen consumption. Mol Pharmacol (1981) 0.81
Comparison and characterization of mammalian xenobiotic ketone reductases. J Pharmacol Exp Ther (1979) 0.80
Prostaglandin B equivalents in human plasma. Prostaglandins (1974) 0.80
Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools. Cancer Res (1981) 0.79
Effects of ascorbic acid on biologically obtained diaziquone free radicals. Biochem Pharmacol (1985) 0.79
Daunorubicin biliary excretion and metabolism in the rat. Arch Int Pharmacodyn Ther (1973) 0.79
Variation amongst K562 cell cultures. Exp Hematol (1983) 0.79
Daunorubicin metabolism in acute myelocytic leukemia. Blood (1972) 0.79
Metabolism of oxyfedrine. Naunyn Schmiedebergs Arch Pharmacol (1972) 0.79
Cellular accumulation and disposition of aclacinomycin A. Cancer Res (1979) 0.79
A method for detecting organic acids on thin-layer and paper chromatograms. Anal Biochem (1965) 0.79
Diurnal rhythm: effects on hepatic regeneration and hepatic regenerative stimulator substance. Science (1978) 0.78
Experimental chemotherapy-induced skin necrosis in swine. Mechanistic studies of anthracycline antibiotic toxicity and protection with a radical dimer compound. J Clin Invest (1988) 0.78
Letter: Contact dermatitis associated with adriamycin (NSC-123127) and daunorubicin (NSC-82151). Cancer Chemother Rep (1975) 0.78
Plasma kinetics of aclacinomycin A and its major metabolites in man. Cancer Chemother Pharmacol (1982) 0.78
Doxorubicin-induced skin necrosis in the swine model: protection with a novel radical dimer. J Clin Oncol (1986) 0.78
Phase II evaluation and plasma pharmacokinetics of high-dose intravenous 6-thioguanine in patients with colorectal carcinoma. Cancer Chemother Pharmacol (1982) 0.78
[2 cases of bilateral chylothorax associated with malignant tumor]. Nihon Kyobu Shikkan Gakkai Zasshi (1986) 0.78
Prevention of adriamycin toxicity. Cancer Chemother Pharmacol (1983) 0.78
Studies on the isozyme of beta-glucuronidase. J Biochem (1965) 0.78
Cellular activation of diaziquone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone] to its free radical species. Biochem Pharmacol (1985) 0.77
Plasma adriamycin and daunorubicin levels by fluorescence and radioimmunoassay. Clin Pharmacol Ther (1977) 0.77
Immunohistochemical localization of cytokeratins in normal eccrine glands, with monoclonal antibodies in routinely processed, formalin-fixed, paraffin-embedded sections. J Am Acad Dermatol (1993) 0.77
Isolation and characterization of rabbit liver xenobiotic carbonyl reductases. Biochem Pharmacol (1980) 0.77
Two-dimensional echocardiographic determinants of interventricular septal configurations in right or left ventricular overload. Am Heart J (1985) 0.77
Effect of hyperthermia on the in vitro metabolism of doxorubicin. Cancer Treat Rep (1986) 0.77
The importance of the techniques employed during the enzymatic preparation of isolated liver parenchymal cells. J Cell Physiol (1973) 0.77
Radical dimer rescue of toxicity and improved therapeutic index of adriamycin in tumor-bearing mice. Cancer Res (1985) 0.77
Mathematical model for adriamycin (doxorubicin) pharmacokinetics. Cancer Chemother Pharmacol (1979) 0.77
Cyclophosphamide plasma and cerebrospinal fluid kinetics with and without dimethyl sulfoxide. Clin Pharmacol Ther (1982) 0.77
Glucuronic acid pathway in alloxan diabetic rabbits. (I). Urinary excretion of metabolites related to the glucuronic acid pathway. Jpn J Pharmacol (1974) 0.77
Human liver daunorubicin reductases. Prog Clin Biol Res (1982) 0.77
Interactions between cyclophosphamide and adriamycin metabolism in rats. J Pharmacol Exp Ther (1984) 0.76
Diaziquone, 2,5-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone, plasma and cerebrospinal fluid kinetics. Clin Pharmacol Ther (1982) 0.76
Cellular pharmocodynamics of several anthrocycline antibiotics. J Med Chem (1976) 0.76
Microsomal reductive glycosidase. J Pharmacol Exp Ther (1976) 0.76
Loss of fluorescence by anthracycline antibiotics: effects of xanthine oxidase and identification of the nonfluorescent metabolites. Cancer Res (1987) 0.76
Initial observations on the effects of delta 9-tetrahydrocannabinol on the plasma pharmacokinetics of cyclophosphamide and doxorubicin. J Clin Pharmacol (1982) 0.75
Daunorubicin metabolism: estimation of daunorubicin reductase. Br J Pharmacol (1971) 0.75